RAPT Therapeutics Inc.
(RAPT)
undefined
undefined%
At close: undefined
0.93
2.00%
After-hours Dec 13, 2024, 07:42 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -116.80M | -83.84M | -69.20M | -52.89M | -43.00M | -36.15M | -29.11M |
| Depreciation & Amortization | 1.22M | 1.05M | 996.00K | 1.12M | 1.33M | 1.24M | 1.38M |
| Stock-Based Compensation | 17.09M | 11.26M | 9.95M | 8.69M | 2.05M | 1.17M | 716.00K |
| Other Working Capital | -1.84M | -5.04M | -5.23M | -46.00K | 3.40M | -691.00K | -34.00K |
| Other Non-Cash Items | -4.06M | 2.09M | 1.53M | 248.00K | 20.00K | -14.00K | -9.00K |
| Deferred Income Tax | - | - | - | - | -11.00K | 17.00K | 15.00K |
| Change in Working Capital | 5.50M | -1.33M | -4.30M | 2.34M | 4.13M | 784.00K | -114.00K |
| Operating Cash Flow | -97.05M | -70.77M | -61.03M | -40.49M | -35.47M | -32.95M | -27.12M |
| Capital Expenditures | -1.13M | -845.00K | -755.00K | -398.00K | -888.00K | -3.50M | -1.12M |
| Acquisitions | - | 44.65M | 80.59M | 87.04M | 45.00K | - | - |
| Purchase of Investments | -161.50M | -190.86M | -164.98M | -139.33M | - | - | - |
| Sales Maturities Of Investments | 266.75M | 146.21M | 84.39M | 52.30M | - | - | - |
| Other Investing Acitivies | - | -44.65M | -80.59M | -87.04M | 45.00K | - | - |
| Investing Cash Flow | 104.13M | -45.49M | -81.35M | -87.44M | -843.00K | -3.50M | -1.12M |
| Debt Repayment | - | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | 1.45M | 1.39M | 2.02M | 1.85M | 14.38M | 105.20M | 59.96M |
| Financial Cash Flow | 1.45M | 131.18M | 141.48M | 75.46M | 49.90M | 52.73M | 30.10M |
| Net Cash Flow | 8.53M | 14.92M | -891.00K | -52.47M | 13.59M | 16.28M | 1.85M |
| Free Cash Flow | -98.17M | -71.62M | -61.78M | -40.89M | -36.36M | -36.45M | -28.25M |